Beam Therapeutics Inc
NASDAQ:BEAM
Beam Therapeutics Inc
NASDAQ:BEAM
Price:
27.93
USD
-5.42%
Market Closed
Market Cap:
$2.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
US |
|
Carlsberg A/S
OTC:CABHF
|
DK |
|
Koninklijke BAM Groep NV
AEX:BAMNB
|
NL |
|
De Grey Mining Ltd
ASX:DEG
|
AU |
|
MM Forgings Ltd
NSE:MMFL
|
IN |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
BMV:BBVA
|
ES |
|
Orange SA
PAR:ORA
|
FR |
|
Morgan Stanley
NYSE:MS
|
US |
Wall St Price Targets
BEAM Price Targets Summary
Beam Therapeutics Inc
Beam Therapeutics Inc
Wall Street analysts forecast BEAM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for BEAM is 51.02 USD with a low forecast of 26.26 USD and a high forecast of 84 USD.
Lowest Forecast
Price Target
26.26
USD
6% Downside
Average Forecast
Price Target
51.02
USD
83% Upside
Highest Forecast
Price Target
84
USD
201% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BEAM's stock price target?
Price Target
51.02
USD
51.02
USD
According to Wall Street analysts, the average 1-year price target for BEAM is 51.02 USD with a low forecast of 26.26 USD and a high forecast of 84 USD.
What is the Revenue forecast for Beam Therapeutics Inc?
Projected CAGR
38%
38%
The compound annual growth rate for Revenue over the next 8 years is 38%.
